Healthcare provider profile · identity verified

William E Childers, M.D.

Internal Medicine · VERSAILLES, KY · NPI 1912900853

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	336	102
Alprazolam	Alprazolam	257	37
Amlodipine Besylate	Amlodipine Besylate	240	80
Lisinopril	Lisinopril	226	82
Omeprazole	Omeprazole	224	73
Gabapentin	Gabapentin	218	41
Levothyroxine Sodium	Levothyroxine Sodium	209	65
Carvedilol	Carvedilol	145	41
Eliquis	Apixaban	145	35
Tamsulosin Hcl	Tamsulosin Hcl	137	44
Losartan Potassium	Losartan Potassium	132	41
Pantoprazole Sodium	Pantoprazole Sodium	124	44
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	107	31
Rosuvastatin Calcium	Rosuvastatin Calcium	106	33
Clonazepam	Clonazepam	105	18
Metoprolol Succinate	Metoprolol Succinate	104	37
Allopurinol	Allopurinol	101	29
Doxazosin Mesylate	Doxazosin Mesylate	97	25
Bupropion Xl	Bupropion Hcl	95	21
Furosemide	Furosemide	95	37
Sertraline Hcl	Sertraline Hcl	92	31
Meloxicam	Meloxicam	90	28
Famotidine	Famotidine	89	26
Metoprolol Tartrate	Metoprolol Tartrate	89	34
Clopidogrel	Clopidogrel Bisulfate	86	28
Potassium Chloride	Potassium Chloride	85	29
Valsartan	Valsartan	85	27
Esomeprazole Magnesium	Esomeprazole Magnesium	84	19
Montelukast Sodium	Montelukast Sodium	84	25
Albuterol Sulfate Hfa	Albuterol Sulfate	83	27
Hydrochlorothiazide	Hydrochlorothiazide	83	34
Diclofenac Sodium	Diclofenac Sodium	78	18
Jardiance	Empagliflozin	76	16
Tramadol Hcl	Tramadol Hcl	75	20
Atenolol	Atenolol	70	22
Torsemide	Torsemide	67	19
Ezetimibe	Ezetimibe	63	22
Metformin Hcl Er	Metformin Hcl	63	22
Dutasteride	Dutasteride	61	19
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	56	17
Glipizide	Glipizide	55	17
Ropinirole Hcl	Ropinirole Hcl	55	15
Metformin Hcl	Metformin Hcl	52	22
Temazepam	Temazepam	50	suppressed
Ipratropium Bromide	Ipratropium Bromide	49	17
Prednisone	Prednisone	47	20
Amitriptyline Hcl	Amitriptyline Hcl	46	12
Carisoprodol	Carisoprodol	46	suppressed
Spironolactone	Spironolactone	44	12
Pravastatin Sodium	Pravastatin Sodium	43	13
Trazodone Hcl	Trazodone Hcl	43	14
Pregabalin	Pregabalin	41	suppressed
Repatha Sureclick	Evolocumab	41	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	40	11
Diazepam	Diazepam	39	suppressed
Finasteride	Finasteride	39	14
Duloxetine Hcl	Duloxetine Hcl	37	11
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	34	13
Synthroid	Levothyroxine Sodium	34	11
Alendronate Sodium	Alendronate Sodium	33	suppressed
Lansoprazole	Lansoprazole	33	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	33	12
Entresto	Sacubitril/Valsartan	32	suppressed
Bumetanide	Bumetanide	30	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	30	12
Glipizide Er	Glipizide	29	suppressed
Warfarin Sodium	Warfarin Sodium	29	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	28	suppressed
Chlordiazepoxide-Amitriptyline	Amitriptyline/Chlordiazepoxide	27	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	27	18
Colestipol Hcl	Colestipol Hcl	27	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	27	20
Levetiracetam	Levetiracetam	27	suppressed
Simvastatin	Simvastatin	27	12
Januvia	Sitagliptin Phosphate	25	suppressed
Fluticasone Propionate	Fluticasone Propionate	24	suppressed
Ondansetron Hcl	Ondansetron Hcl	24	suppressed
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	23	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	23	suppressed
Amiodarone Hcl	Amiodarone Hcl	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	21	suppressed
Celecoxib	Celecoxib	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	21	11
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Sucralfate	Sucralfate	20	suppressed
Doxepin Hcl	Doxepin Hcl	19	suppressed
Mirtazapine	Mirtazapine	19	suppressed
Primidone	Primidone	19	suppressed
Sotalol	Sotalol Hcl	19	suppressed
Tizanidine Hcl	Tizanidine Hcl	19	suppressed
Gemtesa	Vibegron	18	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	18	suppressed
Labetalol Hcl	Labetalol Hcl	17	suppressed
Nitroglycerin	Nitroglycerin	17	14
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	16	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	16	suppressed
Estradiol	Estradiol	16	suppressed
Indomethacin	Indomethacin	16	suppressed
Lorazepam	Lorazepam	16	suppressed
Memantine Hcl Er	Memantine Hcl	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Ramipril	Ramipril	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Acebutolol Hcl	Acebutolol Hcl	15	suppressed
Cefdinir	Cefdinir	15	11
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	15	suppressed
Enalapril Maleate	Enalapril Maleate	15	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	15	suppressed
Promethazine Hcl	Promethazine Hcl	15	suppressed
Topiramate	Topiramate	15	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	15	suppressed
Imipramine Hcl	Imipramine Hcl	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Sulfasalazine	Sulfasalazine	14	suppressed
Sulindac	Sulindac	14	suppressed
Symbicort	Budesonide/Formoterol Fumarate	14	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Colchicine	Colchicine	13	suppressed
Sildenafil Citrate	Sildenafil Citrate	13	suppressed
Buspirone Hcl	Buspirone Hcl	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Linzess	Linaclotide	12	suppressed
Ranolazine Er	Ranolazine	12	suppressed
Rytary	Carbidopa/Levodopa	12	suppressed
Verapamil Er	Verapamil Hcl	12	suppressed
Flecainide Acetate	Flecainide Acetate	11	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error